menu ☰
menu ˟

Targeted radionuclide treatment (MIBG) for a patient, in addition to his current treatment with somatostatin analogues, for metastatic midgut Neuroendocrine tumour (NET) who has multiple bilobar liver metastases and a mesenteric mass

Creator:

Islington PCT

Subject Keywords: Radionuclide therapy, Neuroendocrine tumour, Exceptional treatments, individual treatments, Clinical exceptions
Type: Report
Region: United Kingdom
Description:

refer to the resource

Date:

10/10/2009

Rights: refer to the resource
Suggested citation:

Islington PCT. (2009) Targeted radionuclide treatment (MIBG) for a patient, in addition to his current treatment with somatostatin analogues, for metastatic midgut Neuroendocrine tumour (NET) who has multiple bilobar liver metastases and a mesenteric mass [Online]. Available from: http://publichealthwell.ie/node/214255 [Accessed: 23rd October 2019].

  

View your saved citations and reading lists

Contributor:

APHO
 
Click here to view all the resources gathered from this organisation's website.